InvestLog
IOVA Iovance Biotherapeutics, Inc. logo

IOVA Iovance Biotherapeutics, Inc.

Healthcare
$4.10-0.24%ClosedMarket Cap: $1.47B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

273

13F Shares

261,590,395

Ownership %

71.9%

New Positions

50

Increased Positions

151

Closed Positions

42

Reduced Positions

64

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
CNCRLoncar Cancer Immunotherapy ETF67,4853.47%
BBPVirtus Biotech ETF383,7632.50%
MOONDirexion Moonshot Innovators ETF46,1881.94%
IDNAiShares Genomics Immunology and Healthcare ETF536,8181.23%
WBIO LN23,6550.58%
WDNA LN22,8820.56%
QQQSInvesco NASDAQ Future Gen 200 ETF18,3680.49%
CANCTema Oncology ETF182,9150.40%
XBI8,139,8730.39%
LABUDirexion Daily S&P Biotech Bull 3X ETF407,3980.30%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF1,305,1190.19%
PRFZInvesco RAFI US 1500 Small-Mid ETF1,226,0370.16%
IBBQInvesco Nasdaq Biotechnology ETF24,2270.11%
IBBiShares Biotechnology ETF2,619,0210.11%
GINNGoldman Sachs Innovate Equity ETF52,5730.09%
BIBProShares - Ultra Nasdaq Biotechnology18,4280.09%
VTWV229,6250.08%
NAJ2,894,3980.08%
IWNiShares Russell 2000 Value ETF2,894,3980.08%
AVSCX32,6620.08%